Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes
Open Access
- 30 September 1995
- Vol. 46 (3) , 277-289
- https://doi.org/10.1016/s0090-4295(99)80208-8
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- The Volume of Prostate Cancer in the Biopsy Specimen Cannot Reliably Predict the Quantity of Cancer in the Radical Prostatectomy Specimen on an Individual BasisJournal of Urology, 1995
- Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonistUrology, 1994
- The Dilemmas of Prostate CancerScientific American, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Screening for prostate cancer—Necessity or nonsense?European Journal Of Cancer, 1993
- A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research TeamArchives of Family Medicine, 1993
- Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapyThe Prostate, 1993
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706International Journal of Radiation Oncology*Biology*Physics, 1991
- Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate CancerNew England Journal of Medicine, 1990
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONEThe Lancet, 1988